A

APT Medical Inc
SSE:688617

Watchlist Manager
APT Medical Inc
SSE:688617
Watchlist
Price: 390 CNY -0.76% Market Closed
Market Cap: 37.9B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one APT Medical Inc stock under the Base Case scenario is 292.27 CNY. Compared to the current market price of 390 CNY, APT Medical Inc is Overvalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
292.27 CNY
Overvaluation 25%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

19.2
P/S
P/S
Price to Sales
19.2
vs History
1
vs Industry
7
Median 3Y
15.6
Median 5Y
12.7
Industry
2.2
Forward
17.7
More Details
57.1
P/E
P/E
Price to Earnings
57.1
vs History
3
vs Industry
8
Median 3Y
48.1
Median 5Y
44
Industry
22.5
Forward
52.7
More Details
51.7
P/OCF
P/OCF
Price to OCF
51.7
vs History
1
vs Industry
6
Median 3Y
42.2
Median 5Y
39
Industry
13.9
More Details
1 384
P/FCFE
P/FCFE
Price to FCFE
1 384
vs History
7
vs Industry
0
Median 3Y
76.4
Median 5Y
58.9
Industry
19.7
More Details
17.7
P/B
P/B
Price to Book Value
17.7
vs History
1
vs Industry
2
Median 3Y
13.5
Median 5Y
9.4
Industry
2.1
More Details
18.7
EV/S
EV/S
Enterprise Value to Sales
18.7
vs History
1
vs Industry
7
Median 3Y
14.8
Median 5Y
11.9
Industry
2.3
Forward
17.2
More Details
26.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
26.3
vs History
1
vs Industry
7
Median 3Y
21
Median 5Y
16.9
Industry
4.9
More Details
51.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
51.3
vs History
5
vs Industry
6
Median 3Y
43
Median 5Y
39
Industry
11.9
Forward
42.9
More Details
51.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
51.3
vs History
5
vs Industry
8
Median 3Y
43
Median 5Y
39
Industry
16.4
Forward
45.1
More Details
50.3
EV/OCF
EV/OCF
Enterprise Value to OCF
50.3
vs History
1
vs Industry
6
Median 3Y
40.3
Median 5Y
35.7
Industry
13.7
More Details
350.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
350.6
vs History
1
vs Industry
2
Median 3Y
71.2
Median 5Y
59.6
Industry
17.2
More Details
21.9
EV/IC
EV/IC
Enterprise Value to IC
21.9
vs History
15
vs Industry
3
Median 3Y
18.6
Median 5Y
17.9
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
APT Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
APT Medical Inc
SSE:688617
37.6B CNY 19.2 57.1 51.3 51.3
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
65.8B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
57.1B EUR 2.5 28.8 16.4 23.4
US
Edwards Lifesciences Corp
NYSE:EW
41.8B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.4 12.9 15.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.